Dr. Kimberly Clark, Head of Research and Development at Viiv Healthcare, joins us to discuss the current status of the HIV Epidemic, and the benefits of the first long-acting HIV medication, Apretude.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
